BARD1 and neoplasm: BARD1, well known as a BRCA1 partner, is considered a tumor suppressor due to its impact on cell cycle progression, apoptosis, gene expression regulation, RNA processing and DNA repair mechanisms, either conjugated with BRCA1 in a stable heterodimer through the interaction of their respective RING finger domains, or in its monomeric form [7-16].